Status:
COMPLETED
Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Schizophrenia
Eligibility:
MALE
18-40 years
Phase:
PHASE1
Brief Summary
This study will assess transcranial magnetic stimulation (TMS) as a biomarker and characterize TMS readouts of the activity of MK2637 and dextromethorphan. Resting quantitative electroencephalography(...
Eligibility Criteria
Inclusion
- Subject is right-handed
- Subject is in good health
- Subject is a nonsmoker
Exclusion
- Subject works a night shift
- Subject has a history of any illness that might make participation in the study unsafe or confound the study results
- Subject has a history of head injury
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00934466
Start Date
July 1 2009
End Date
December 1 2009
Last Update
June 24 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.